Last reviewed · How we verify

NCT03173807: ProNEST

Prostate Nutrition and Exercise STudy (ProNEST)

Withdrawn NA Last updated 6 October 2017
What this trial tests

NA trial testing diet and exercise guidance and modifications in Metabolic Syndrome. Withdrawn.

Timeline
31 August 2017
Primary endpoint
31 December 2019
31 December 2021

Quick facts

Lead sponsorUniversity of Pittsburgh
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Start date31 August 2017
Primary completion31 December 2019
Estimated completion31 December 2021

Drugs / interventions tested

Conditions studied

Sponsor

University of Pittsburgh

Who can join

18 and older, male only, with Metabolic Syndrome or Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to test the feasibility of nutrition and exercise counseling program for reducing the incidence of metabolic syndrome in prostate cancer patients on Androgen Deprivation Therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

Other University of Pittsburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03173807.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing